Related Experiment Video
Updated: Apr 15, 2026

Phosphoproteomic Strategy for Profiling Osmotic Stress Signaling in Arabidopsis
Published on: June 25, 2020
5,5'-Methylenedisalicylic Acid (MDSA) Modulates SarA/MgrA Phosphorylation by Targeting Ser/Thr Phosphatase Stp1
Weihao Zheng1, Yujie Liang, Hui Zhao
1Key Lab of Chemical Genomics, School of Chemical Biology and Biotechnology, Shenzhen Graduate School, Peking University, Shenzhen 518055 (China).
Abstract:
SarA (staphylococcal accessory protein A), MgrA (MarR family of global transcriptional regulator A), and SarZ (a paralogue of SarA) play critical roles in modulating the virulence, drug resistance and autolysis of Staphylococcus aureus. Recently, eukaryotic-like Ser/Thr kinase/phosphatases (Stk1/Stp1) were found to modulate phosphorylation of these transcriptional regulators as well as staphylococcal virulence. Importantly, an stp1-deficient strain showed significant virulence reduction in mice, indicative of Stp1 as a potential drug target. Here, we report that MDSA, an inhibitor of MgrA, enhances phosphorylation of SarA/MgrA by inhibiting Stp1 in S. aureus. MDSA is a more-potent inhibitor (IC50 =9.68 ± 0.52 μM) of Stp1 than commonly used phosphatase inhibitors. We anticipate that MDSA could be a lead compound to develop new approaches for reducing staph virulence by targeting Stp1.
Insights
MDSA inhibits staphylococcal Ser/Thr phosphatase 1 (Stp1), enhancing SarA/MgrA phosphorylation. This discovery offers a new strategy for developing drugs to reduce Staphylococcus aureus virulence.
Area of Science:
- Microbiology
- Molecular Biology
- Drug Discovery
Background:
- Key transcriptional regulators SarA, MgrA, and SarZ control Staphylococcus aureus virulence, drug resistance, and autolysis.
- Eukaryotic-like Ser/Thr kinases/phosphatases (Stk1/Stp1) modulate these regulators and influence S. aureus virulence.
- Stp1 is a potential drug target, as an stp1-deficient strain exhibits reduced virulence in mice.
Purpose of the Study:
- To investigate the effect of MDSA, an MgrA inhibitor, on SarA/MgrA phosphorylation in S. aureus.
- To determine if MDSA affects Stp1 activity.
- To evaluate MDSA as a potential lead compound for anti-virulence drug development.
Main Methods:
- Utilized Staphylococcus aureus strains.
- Investigated the inhibitory effects of MDSA on Stp1 phosphatase activity.
- Quantified SarA/MgrA phosphorylation levels.
- Determined the IC50 of MDSA against Stp1.
Main Results:
- MDSA inhibits Stp1 phosphatase activity in S. aureus.
- MDSA treatment leads to enhanced phosphorylation of SarA and MgrA.
- MDSA demonstrates potent inhibition of Stp1 (IC50 = 9.68 ± 0.52 μM), exceeding that of common phosphatase inhibitors.
Conclusions:
- MDSA enhances SarA/MgrA phosphorylation by inhibiting Stp1 in S. aureus.
- MDSA is a potent Stp1 inhibitor, suggesting its potential as a lead compound.
- Targeting Stp1 with compounds like MDSA offers a promising avenue for developing novel anti-virulence strategies against Staphylococcus aureus.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
MAPK Signaling Cascades
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

